
1. malar j. 2015 dec 21;14:511. doi: 10.1186/s12936-015-1028-1.

dysregulation haem-haemopexin axis associated severe malaria 
case-control study ugandan children.

elphinstone re(1)(2)(3), riley f(4), lin t(5), higgins s(6)(7)(8), dhabangi a(9),
musoke c(10), cserti-gazdewich c(11), regan rf(12), warren hs(13), kain
kc(14)(15)(16).

author information: 
(1)sandra rotman centre global health, university health network-toronto
general hospital, toronto, on, canada. robyn.elphinstone@mail.utoronto.ca.
(2)department laboratory medicine pathobiology, university toronto,
toronto, on, canada. robyn.elphinstone@mail.utoronto.ca.
(3)tropical disease unit, department medicine, university toronto, toronto,
on, canada. robyn.elphinstone@mail.utoronto.ca.
(4)infectious disease unit, department pediatrics, massachusetts general
hospital, boston, ma, usa. friley@mgh.harvard.edu.
(5)infectious disease unit, department pediatrics, massachusetts general
hospital, boston, ma, usa. tlin7@mgh.harvard.edu.
(6)sandra rotman centre global health, university health network-toronto
general hospital, toronto, on, canada. sjhiggin@bidmc.harvard.edu.
(7)department laboratory medicine pathobiology, university toronto,
toronto, on, canada. sjhiggin@bidmc.harvard.edu.
(8)tropical disease unit, department medicine, university toronto, toronto,
on, canada. sjhiggin@bidmc.harvard.edu.
(9)makerere university college health sciences, kampala, uganda.
adhabangi@gmail.com.
(10)makerere university college health sciences, kampala, uganda.
jxyug@yahoo.com.
(11)laboratory medicine program (transfusion medicine), university health
network/university toronto, toronto, on, canada. christine.cserti@uhn.ca.
(12)department emergency medicine, thomas jefferson university, philadelphia, 
pa, usa. raymond.regan@jefferson.edu.
(13)infectious disease unit, department pediatrics, massachusetts general
hospital, boston, ma, usa. warren@helix.mgh.harvard.edu.
(14)sandra rotman centre global health, university health network-toronto
general hospital, toronto, on, canada. kevin.kain@uhn.ca.
(15)department laboratory medicine pathobiology, university toronto,
toronto, on, canada. kevin.kain@uhn.ca.
(16)tropical disease unit, department medicine, university toronto,
toronto, on, canada. kevin.kain@uhn.ca.

background: malaria associated haemolysis release plasma haem.
plasma haem cause endothelial injury organ dysfunction, normally
scavenged haemopexin limit toxicity. hypothesized dysregulation
of haem-haemopexin pathway contributes severe fatal malaria
infections.
methods: plasma levels haemin (oxidized haem), haemopexin, haptoglobin, and
haemoglobin quantified case-control study ugandan children with
plasmodium falciparum malaria. levels presentation compared children
with uncomplicated malaria (um; n = 29), severe malarial anaemia (sma; n = 27) or
cerebral malaria (cm; n = 31), evaluated utility predicting fatal
(n = 19) vs non-fatal (n = 39) outcomes severe disease. causal role for
haemopexin assessed pre-clinical model experimental cerebral malaria 
(ecm), following disruption mouse haemopexin gene (hpx). analysis done
using kruskall wallis tests, mann-whitney tests, log-rank tests survival, and
repeated measures anova.
results: ugandan children presenting p. falciparum malaria, haemin levels
were higher haemopexin levels lower sma cm compared children
with um (haemin, p < 0.01; haemopexin, p < 0.0001). among cases severe
malaria, elevated levels haemin cell-free haemoglobin presentation were
associated subsequent mortality (p < 0.05). compared ecm-resistant balb/c
mice, susceptible c57bl/6 mice lower circulating levels haemopexin
(p < 0.01), targeted deletion haemopexin gene, hpx, resulted in
increased mortality compared wild type littermates (p < 0.05).
conclusions: data indicate plasma levels haemin haemopexin
measured presentation correlate malaria severity levels haemin and
cell-free haemoglobin predict outcome paediatric severe malaria. mechanistic
studies ecm model support causal role haem-haemopexin axis in
ecm pathobiology.

doi: 10.1186/s12936-015-1028-1 
pmcid: pmc4687388
pmid: 26691827  [indexed medline]

